Miguel Forte

Chief Executive Officer • Bone Therapeutics

Dr. Forte has significant experience in regenerative medicine and in the cell therapy industry, most recently as Chief Executive Officer of Zelluna Immunotherapy, a biopharma company focusing on developing transformative T cell receptors (TCR) based cellular immunotherapies for the treatment of cancers. He is currently also serving as Chief Commercialization Officer and Chair of the Commercialization Committee of the International Society of Cellular Therapy (ISCT).

Also Speaking

Jason C. Foster

Chief Executive Officer • Ori Biotech

Julia Tarasenko

VP, Commercial Operations, EMEA and Americas • Marken

Michael Lehmicke

Senior Director, Science and Industry Affairs  • Alliance for Regenerative Medicine

Event Info


Fun Run